The microbiome represents an assemblage of a complex community of microbes (bacteria,
archaea, fungi, algae, protists, and viruses) and their biomolecules occupying a well-defined
habitat in or on a living or non-living object. Symbiotic microorganisms inhabiting the
gastrointestinal tract promote health by decreasing susceptibility to infection and enhancing
resistance to a range of diseases.

Microbiome Based Therapy

The Senate of the Italian Republic approved on July 19, the bill preventing the
production and import of cultivated products, with the aim to protect national
interest, food heritage and consumers' health. Out of the 154 senators in the
highest chamber, 93 voted in favour of the bill for the "the protection of human
health and the environment in relation to the production, marketing and
importation of foods of non-animal origin". The bill still needs to go through the
Chamber of Deputies to be fully approved. If approved, Italy would become the
first country to ban the marketing, importation, and production of synthetic
food.

Ban to cultured meat within its borders by Italy

DDE is constantly working to provide smarter technologies, systems and solutions to healthcare companies. For the last 30 years, our focus has been to develop smarter innovations. Today, DDE houses 350+ engineers, technicians, designers, biotechnologists, researchers and experts working at the intersection of technology and healthcare sciences to solve some of the industry’s toughest problems.

Cultured Fish

CAR-T treatment

Recent advances in biotechnology have enabled a precision medicine field with great promise
for preventing and treating many diseases, to excel. Termed mRNA-based therapeutics or
vaccines; this field promises great hope to combat a wide range of incurable diseases. Any
functional protein/peptide can be produced in the human body by introducing mRNA as a
vaccine or therapeutic agent. mRNA with programmed production, is more effective, faster in
design and production, as well as more flexible and cost-effective than conventional
approaches that are followed.

mRNA based therapeutics and vaccines- An overview

There’s a lot of pressure on biopharma companies and their input suppliers to bring routine medications and immune system boosters to the market faster. Thus, these businesses are increasingly adopting modular systems to rapidly scale the manufacturing process, keeping costs to a minimum. Key among them are process skids.

 

A process skid is a self-contained production environment – “a system in a box,” capable of easy transportation with little effort. Multiple skids, entirely fabricated and integrated at cost-friendly offsite locations, can be shipped to the manufacturing site, where the last bit of civil site upgrades happen. Individual modules can be set up, using repeatable processes to the existing production infrastructure increasing throughput and meeting growing demand. Process skids also lend themselves to a high degree of customisation.

 

Cost-Effective Modular Skid Approach v. Overpriced Onsite Constructions
By reducing the construction and ongoing maintenance effort at the manufacturing site, modular process skids help cut back time-to-production and save on capital costs. With its reduced labor component and repeatable processes, it emerges as a cost-efficient, alternative to traditional constructions. In conventional construction, processing systems are shipped in parts and assembled entirely at the site.


To read more>>>https://www.ddentp.com/blog-single?id=c51ce410c124a10e0db5e4b97fc2af39

Process Skids As Sustainable And Cost-friendly Solutions In The Biopharma Sector

DD ENTERPRISES

Related tracks